Completed

Use of Nutritional Supplements and CAM (Complementary and Alternative Medicine) by Prostate and Breast Cancer Patients Undergoing Radiotherapy

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Other
Who is being recruted

Urogenital Diseases+11

+ Genital Diseases

+ Breast Diseases

From 21 to 70 Years
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: December 2002
See protocol details

Summary

Principal SponsorOhio State University Comprehensive Cancer Center
Last updated: December 29, 2025
Sourced from a government-validated database.Claim as a partner

Study start date: December 11, 2002

Actual date on which the first participant was enrolled.

This study was a survey to determine the frequency of Complementary and Alternative Medicine (CAM) use in patients recently diagnosed with breast or prostate cancer who were starting radiation therapy. The survey was repeated at three time points to assess changes in CAM use over time.

NCT01823549
Principal SponsorOhio State University Comprehensive Cancer Center
Last updated: December 29, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

109 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 21 to 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesGenital DiseasesBreast DiseasesGenital Diseases, MaleGenital Neoplasms, MaleNeoplasmsNeoplasms by SiteProstatic DiseasesSkin DiseasesUrogenital NeoplasmsSkin and Connective Tissue DiseasesMale Urogenital DiseasesBreast NeoplasmsProstatic Neoplasms

Criteria

Inclusion/Exclusions Men that have histologically proven carcinoma of the prostate and have chosen some form of radiation therapy as their primary therapy for prostate cancer. Women who are undergoing external beam radiation therapy to the breast as primary or adjuvant therapy are eligible. All participants must be able to read and write. Subjects with dementia and mental retardation that complicates completing the questionnaires will not be enrolled. Subjects with known metastatic disease will be excluded. There are no age restrictions for this study.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Ohio State University Comprehensive Cancer Center

Columbus, United StatesOpen Ohio State University Comprehensive Cancer Center in Google Maps
CompletedOne Study Center